Importer of Controlled Substances Application: Globyz Pharma, LLC, 11333 [2021-03834]
Download as PDF
<![CDATA[
11333
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
Controlled substance
Drug code
Anileridine ........................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine Intermediate-A ..............................................................................................................................................
Meperidine Intermediate-B ..............................................................................................................................................
Meperidine Intermediate-C ..............................................................................................................................................
Dextropropoxyphene .......................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
William T. McDermott,
Assistant Administrator.
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
[FR Doc. 2021-03758 Filed 2-21; 8:45 am]
SUPPLEMENTARY INFORMATION:
The company plans to manufacture
the above listed controlled substances as
analytical reference materials,
proficiency test materials and academic
research materials for distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
In
accordance with 21 CFR 1301.34(a), this
is notice that on September 30, 2020,
Globyz Pharma, LLC, 2101 Market
Street, Suite 5, Upper Chichester,
Pennsylvania 19061–4001, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–790]
Importer of Controlled Substances
Application: Globyz Pharma, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Controlled
substance
Drug
code
Schedule
Oxycodone .....................
9143
II
AGENCY:
Globyz Pharma, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
The company plans to import the
listed controlled substance to complete
analytical testing. No other activity for
these drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03834 Filed 2–23–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
9020
9170
9180
9220
9230
9232
9233
9234
9273
9648
9737
9739
9740
9743
9780
9801
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF LABOR
Mine Safety and Health Administration
Petitions for Modification of
Application of Existing Mandatory
Safety Standards
Mine Safety and Health
Administration, Labor.
ACTION: Notice.
AGENCY:
This notice is a summary of
a petition for modification submitted to
the Mine Safety and Health
Administration (MSHA) by the party
listed below.
DATES: All comments on the petition
must be received by MSHA’s Office of
Standards, Regulations, and Variances
on or before March 26, 2021.
ADDRESSES: You may submit your
comments, identified by ‘‘docket
number’’ on the subject line, by any of
the following methods:
1. Electronic Mail: zzMSHAcomments@dol.gov. Include the docket
number of the petition in the subject
line of the message.
2. Facsimile: 202–693–9441.
3. Regular Mail or Hand Delivery:
MSHA, Office of Standards,
Regulations, and Variances, 201 12th
Street South, Suite 4E401, Arlington,
Virginia 22202–5452, Attention: S.
Aromie Noe, Acting Deputy Director,
Office of Standards, Regulations, and
Variances. Persons delivering
documents are required to check in at
the receptionist’s desk in Suite 4E401.
Individuals may inspect copies of the
petition and comments during normal
business hours at the address listed
above.
MSHA will consider only comments
postmarked by the U.S. Postal Service or
proof of delivery from another delivery
service such as UPS or Federal Express
on or before the deadline for comments.
SUMMARY:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Page 11333]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03834]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-790]
Importer of Controlled Substances Application: Globyz Pharma, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Globyz Pharma, LLC has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 26, 2021.
Such persons may also file a written request for a hearing on the
application on or before March 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on September 30, 2020, Globyz Pharma, LLC, 2101 Market
Street, Suite 5, Upper Chichester, Pennsylvania 19061-4001, applied to
be registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Oxycodone.............................. 9143 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance to
complete analytical testing. No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03834 Filed 2-23-21; 8:45 am]
BILLING CODE 4410-09-P
